三友医疗(688085) - 20240523投资者关系活动记录表2024-002

Group 1: Product Overview and Market Strategy - The company's main products include spinal and trauma implants, as well as ultrasonic power systems [1][2] - The international market strategy combines technology output with local brands in Europe and the US [2] - The acquisition of French orthopedic company Implanet has been completed, enhancing the company's market presence [2] Group 2: Financial Performance and Challenges - The company's net profit has declined year-on-year, primarily due to the implementation of national volume-based procurement for high-value spinal consumables, leading to significant price drops [2] - Plans are in place to enrich the product line in traditional spinal and trauma fields while maintaining technological leadership [2] Group 3: Research and Development Initiatives - The company aims to increase R&D investment to develop innovative therapies and products, maintaining a leading position in the domestic spinal consumables market [3] - Focus areas for R&D include new materials, sports medicine, surface modification of biomaterials, 3D printing, next-generation surgical robots, and spinal segment prosthetics [3]